 Home > Medical News > Latest Medical News > TJ-CD4B bispecific antibody TJ-CD4B is approved for Phase 1 clinical trial in China

TJ-CD4B bispecific antibody TJ-CD4B is approved for Phase 1 clinical trial in China

 Last Update: 2022-01-11
 Source: Internet
 Author: User

Tags

berberine cancer

antigen antibody complex

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On December 15th, TJBio announced that CDE has officially approved the bispecific antibody TJ-CD4B (also known as ABL111) to treat solid tumors (including gastric cancer, esophageal-gastric junction adenocarcinoma, esophageal adenocarcinoma, and pancreatic duct adenocarcinoma).

TJ-CD4B is the first clinically innovative bispecific antibody targeting the tumor antigen claudin 18 splicing body 2 (Claudin 18.

TJBio has been approved in the United States in June this year to initiate a phase 1 clinical trial of TJ-CD4B for the treatment of advanced solid tumors (NCT04900818).

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

TJBio announces that its bispecific antibody TJ-CD4B has been approved for Phase 1 clinical trials in China

12-27

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

TJ-CD4B bispecific antibody TJ-CD4B is approved for Phase 1 clinical trial in China

Related Articles

TJBio announces that its bispecific antibody TJ-CD4B has been approved for Phase 1 clinical trials in China